HROW Harrow, Inc.
$34.48▼ -5.74%
Healthcare
Other
After hours
$34.63▲ +0.44%
Sep 11, 7:30 PM ET
Volume 987.4K
Avg Volume (10D) 400.0K
Key Metrics & Fundamentals
Market Cap
$1.29B
P/E Ratio
–
Div Yield
–%
52W Range
28.54 - 54.85
% vs 50 MA
-14.64%
% vs 200 MA
-16.40%
RSI-14
33.2
MACD Histogram
-0.3300
Beta (1Y vs SPY)
1.41
Free Cash Flow
-$10.29M
Gross Rev
$70.66M
Gross Profit
$50.36M
EBITDA
-$4.82M
COGS
$20.30M
Operating Exp
$61.37M
Operating Income
-$11.01M
EBIT
-$11.01M
Pretax Income
-$17.27M
Net Income
-$17.27M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target
MT Newswires · Sep 9, 2026 11:52 AM
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks
Insider Monkey · Sep 3, 2026 2:44 PM
Harrow to Participate in Three Investor Conferences in September
GlobeNewswire · Sep 1, 2026 11:00 AM
Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target
Insider Monkey · Aug 20, 2026 12:24 PM
Harrow's IHEEZO Cuts Patient-Reported Discomfort 58% in Intravitreal-Injection Study
MT Newswires · Aug 20, 2026 11:46 AM
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
GlobeNewswire · Aug 20, 2026 11:00 AM
Harrow (HROW) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 17, 2026 11:43 PM
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
Insider Monkey · Aug 13, 2026 11:03 PM
Harrow (HROW) Adds New Eye Care Firepower With Product Launch And Acquisition
Simply Wall St. · Aug 12, 2026 9:10 AM
Harrow Inc (HROW) (Q2 2026) Earnings Call Highlights: Record Demand and Strategic Expansion ...
GuruFocus.com · Aug 11, 2026 7:01 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See HROW's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.